Skip To Main Content
Laura Cowen on Muck Rack

Laura Cowen

Verified
United Kingdom
As seen in: InfoQ, DZone, Genetic Literacy Project, News Medical, Genetic Engineering & Biotechnology News, Labiotech, StartupNation, Inside Precision Medicine, Medicine Matters Diabetes, Medicine Matters Oncology and
Covers:  Oncology, Diabetes, Infectious Disease, Precision Medicine, Biotech, Cardiology, Respiratory Medicine, Most other aspects of healthcare

Get in touch with Laura

Contact Laura, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Laura Cowen’s Journalist Portfolio

See all →
From Reactive to Proactive: Reimagining Hypertension Management in the Precision Medicine Era

From Reactive to Proactive: Reimagining Hypertension Management in the Precision Medicine Era

Despite the size of the hypertension problem, its diagnosis and treatment pathway has remained largely the sa…

View article →
Ensuring Diagnostic Stewardship Through Molecular Point-of-Care Testing

Ensuring Diagnostic Stewardship Through Molecular Point-of-Care Testing

In the field of infectious diseases, rapid and precise diagnosis is important to ensure not only timely treat…

View article →
The Expanding Frontier of Metabolomics in Precision Medicine: Spatial, Single-Cell, Real-Time, an...

The Expanding Frontier of Metabolomics in Precision Medicine: Spatial, Single-Cell, Real-Time, an...

Unlike genomics or transcriptomics, which describe potential or intermediate states, metabolomics reflects th…

View article →
Unpacking the Complexities of Companion Diagnostics for Cell and Gene Therapies

Unpacking the Complexities of Companion Diagnostics for Cell and Gene Therapies

In a world of increasingly precise therapies, companion diagnostics (CDx) are gaining importance. Yet the nee…

View article →
The Nonprofit Organizations Identifying New Therapeutic Uses for Existing Drugs

The Nonprofit Organizations Identifying New Therapeutic Uses for Existing Drugs

Despite benefits of repurposed drugs, the focus within the pharmaceutical industry remains on new drugs, leav…

View article →
Building a Bridge Between Rare Disease Patients and the Technologies that Could Help Them

Building a Bridge Between Rare Disease Patients and the Technologies that Could Help Them

Julia Vitarello is on a personal mission to open up access to individualized therapies for people with rare d…

View article →

Articles

Prostate Cancer Genomic Analysis Links Mutational Footprints to Clinical Outcomes

|
By Laura Cowen Verified
| Inside Precision Medicine Verified
Credit: wildpixel/Getty Images An analysis of nearly 1000 prostate tumor samples has revealed eight integrated mutational footprints (IMFs) that underpin the majority of genetic alterations found in prostate cancer genomes, some of which reflect clinical outcomes.
Open in Who Shared Issue with article?

Targetable KRAS G12C Mutation Uncommon in Genitourinary Cancers

|
By Laura Cowen Verified
| Inside Precision Medicine Verified
Credit: magicmine / Getty Images A comprehensive genomic profiling study involving more than 13,000 patients has shown that targetable G12C mutations in the KRAS oncogene are rare in genitourinary cancers, potentially limiting the role of routine testing and targeted treatment in these malignancies.
Open in Who Shared Issue with article?

Researchers Call for Biologically-Tailored Treatment for Mantle Cell Lymphoma

|
By Laura Cowen Verified
| Inside Precision Medicine Verified
Credit: xfzsy/Getty Images European researchers have proposed a biomarker-based treatment algorithm for patients with mantle cell lymphoma that could move treatment decisions beyond age and transplant eligibility toward individualized strategies based on disease biology and treatment response.
Open in Who Shared Issue with article?
See all 2,214 articles

Interview

See all →

Have you ever used a typewriter?

No

Who's your favorite fictional journalist?

Dexter Fletcher's character in Press Gang

How do you prefer to be pitched on stories?

Email